Methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate
C24H28N2O5 — CID 25246687
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate
Methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate (PubChem CID 25246687) has the molecular formula C24H28N2O5 and a molecular weight of 424.50 g/mol. Its IUPAC name is methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate.
Molecular Properties
| Compound Name | Methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate |
|---|---|
| PubChem CID | 25246687 |
| Molecular Formula | C24H28N2O5 |
| Molecular Weight | 424.50 g/mol |
| Exact Mass | 424.20 |
| IUPAC Name | methyl 2-(3-methoxyphenyl)-2-[[1-[(4-methoxyphenyl)methyl]-3,4-dimethyl-5-oxo-2H-pyrrol-2-yl]amino]acetate |
| SMILES | COC(=O)C(NC1C(C)=C(C)C(=O)N1Cc1ccc(OC)cc1)c1cccc(OC)c1 |
| InChI | InChI=1S/C24H28N2O5/c1-15-16(2)23(27)26(14-17-9-11-19(29-3)12-10-17)22(15)25-21(24(28)31-5)18-7-6-8-20(13-18)30-4/h6-13,21-22,25H,14H2,1-5H3 |
| InChIKey | LQSRVDBUUOFYMZ-UHFFFAOYSA-N |
| XLogP | 3.21 |
| TPSA | 77.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.50 |
| LogP ≤ 5 | 3.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25246687 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.